Follow
Victor H Engelhard
Victor H Engelhard
Professor of Microbiology, Immunology, and Cancer Biology, University of Virginia
Verified email at virginia.edu - Homepage
Title
Cited by
Cited by
Year
Characterization of peptides bound to the class I MHC molecule HLA-A2. 1 by mass spectrometry
DF Hunt, RA Henderson, J Shabanowitz, K Sakaguchi, H Michel, N Sevilir, ...
Science 255 (5049), 1261-1263, 1992
16891992
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
AL Cox, J Skipper, Y Chen, RA Henderson, TL Darrow, J Shabanowitz, ...
Science 264 (5159), 716-719, 1994
11511994
HLA-A2. 1-associated peptides from a mutant cell line: a second pathway of antigen presentation
RA Henderson, H Michel, K Sakaguchi, J Shabanowitz, E Appella, ...
Science 255 (5049), 1264-1266, 1992
6921992
Cell-cell adhesion mediated by CD8 and MHC class I molecules
AM Norment, RD Salter, P Parham, VH Engelhard, DR Littman
Nature 336 (6194), 79-81, 1988
6501988
Structure of peptides associated with class I and class II MHC molecules
VH Engelhard
Annual review of immunology 12 (1), 181-207, 1994
5861994
Identification of a graft versus host disease-associated human minor histocompatibility antigen
JMM den Haan, NE Sherman, E Blokland, E Huczko, F Koning, ...
Science 268 (5216), 1476-1480, 1995
5441995
The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism
JMM Den Haan, LM Meadows, W Wang, J Pool, E Blokland, TL Bishop, ...
Science 279 (5353), 1054-1057, 1998
5301998
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.
JC Skipper, RC Hendrickson, PH Gulden, V Brichard, A Van Pel, Y Chen, ...
The Journal of experimental medicine 183 (2), 527-534, 1996
5281996
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.
AY Huang, PH Gulden, AS Woods, MC Thomas, CD Tong, WEI Wang, ...
Proceedings of the National Academy of Sciences 93 (18), 9730-9735, 1996
5091996
Human HY: a male-specific histocompatibility antigen derived from the SMCY protein
W Wang, LR Meadows, JMM den Haan, NE Sherman, Y Chen, ...
Science 269 (5230), 1588-1590, 1995
4311995
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating …
CL Slingluff Jr, GR Petroni, GV Yamshchikov, DL Barnd, S Eastham, ...
Journal of Clinical Oncology 21 (21), 4016-4026, 2003
4202003
Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation
JN Cohen, CJ Guidi, EF Tewalt, H Qiao, SJ Rouhani, A Ruddell, AG Farr, ...
Journal of Experimental Medicine 207 (4), 681-688, 2010
4032010
NKT cell activation mediates neutrophil IFN-γ production and renal ischemia-reperfusion injury
L Li, L Huang, SJ Sung, PI Lobo, MG Brown, RK Gregg, VH Engelhard, ...
The Journal of Immunology 178 (9), 5899-5911, 2007
3922007
The HLA-A* 0201-restricted HY antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition
L Meadows, W Wang, JMM den Haan, E Blokland, C Reinhardus, ...
Immunity 6 (3), 273-281, 1997
3511997
Structure of peptides associated with MHC class I molecules
VH Engelhard
Current opinion in immunology 6 (1), 13-23, 1994
3471994
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation
CM Lappas, YJ Day, MA Marshall, VH Engelhard, J Linden
The Journal of experimental medicine 203 (12), 2639-2648, 2006
3422006
Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy
AL Zarling, JM Polefrone, AM Evans, LM Mikesh, J Shabanowitz, ...
Proceedings of the National Academy of Sciences 103 (40), 14889-14894, 2006
3012006
Phase I Trial of a Melanoma Vaccine with gp100280–288 Peptide and Tetanus Helper Peptide in Adjuvant: Immunologic and Clinical Outcomes
CL Slingluff Jr, G Yamshchikov, P Neese, H Galavotti, S Eastham, ...
Clinical Cancer Research 7 (10), 3012-3024, 2001
2972001
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
ED Thompson, HL Enriquez, YX Fu, VH Engelhard
Journal of Experimental Medicine 207 (8), 1791-1804, 2010
2962010
Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional …
DW Mullins, SL Sheasley, RM Ream, TNJ Bullock, YX Fu, VH Engelhard
The Journal of experimental medicine 198 (7), 1023-1034, 2003
2892003
The system can't perform the operation now. Try again later.
Articles 1–20